Patients
at the center
Who we are
We are an international umbrella liver patient-led association. Our purpose is to represent and advocate for all patients affected by liver disease in both policy and operational contexts and promote equal access to effective areas of liver healthcare.
What we do
We undertake activities to improve care and treatment for people who are affected by, or at the risk, of a liver condition. We work in a progressive and collaborative way, ensuring meaningful engagement and partnerships with other stakeholders.
Research news from Takeda Alpha 1 Antitrypsin. Learn more about the Alpha 1 Liver Disease!
If you or any of your family members have a confirmed or suspected diagnosis...
What Matters Most? The questions every hepatologist should ask their patients
EASL Studio has recently released an episode; “What matters most? The...
PBC Master Sequence Video
Sunday 14 September is International PBC day! Join us and click on the video!
September 13th is Primary Biliary Cholangitis (PBC) Awareness Day
This year’s theme is “Ask me about PBC”, a conversation starter involving the...
World Hepatitis Summit 28 -30 April 2026 in Bangkok Thailand
https://worldhepatitissummit.org/ Are you planning to attend? Please contact...
World Hepatitis Day 2025
World Hepatitis Day 2025 – Let’s Break It Down World Hepatitis Day is...
EASL Congress 27 – 30 May 2026
From 27-30 May, Fira, Barcelona, Spain will be the home of hepatology! The...
STEATOTIC LIVER DISEASE
International brochure about Steatotic Liver Disease Here information about...
Innovations in Steatotic Liver Disease
The People-First Liver Charter Is Out! ISGlobal took initiative to publish...
The uncertain future of Obeticholic Acid in Europe
More than ever it it is extremely important to include the voice of...
















